Matine Charles - Insider Non-Derivative Transactions at Bionik Laboratories Corp. (BNKL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 9, 2023, Matine Charles's relationship to Bionik Laboratories Corp. (BNKL) is Director, and currently has 206,985 shares of Common Stock, par value $0.001 per share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BNKL insiders.
Data Source: SEC.
Matine Charles - Insider Non-Derivative Transactions at BNKL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 10, 2023 | P -- (Common Stock, par value $0.001 per share) | 180555 | 0.6 | 206985 |